Atlas Trials

Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula

Clinical trial NCT02414204 · COMPLETED

Trial details

NCT number
NCT02414204
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Improve Endothelial Function and Decrease Vascular Stenosis
Start date
2015-04-01
Primary completion
2017-06-30
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.